Study on the Effects of National Volume-Based Procurement of Chemical Drugs on Chinese Patent Medicines:Lipid-Lowering Drugs as an ExampleOA
Study on the Effects of National Volume-Based Procurement of Chemical Drugs on Chinese Patent Medicines:Lipid-Lowering Drugs as an Example
Zhao Yang;Xiao Han;Pei Liang;Xiaoting Zhao;Qiyun Zhu;Hui Ye;Chao Yang;Bin Jiang
Center for Digital Health and Artificial Intelligence,Peking University First Hospital,Beijing,ChinaResearch Center of Public Policy,Peking University,Beijing,ChinaSchool of Public Health,Shanghai Jiaotong University,Shanghai,ChinaWomen and Children's Hospital of Chongqing Medical University,Chongqing Health Center for Women and Children,Chongqing,ChinaSchool of Pharmaceutical Sciences,Peking University,Beijing,ChinaRevelle College,University of California San Diego,San Diego,California,USATCM-Integrated TCM&Western Medicine Dept,Peking University First Hospital,Beijing,ChinaCenter for Digital Health and Artificial Intelligence,Peking University First Hospital,Beijing,China
Chinese patent medicinehealth policylipid-lowering drugsnational volume-based procurement
Chinese patent medicinehealth policylipid-lowering drugsnational volume-based procurement
《科学医疗（英文）》 2025 (1)
14-24,11
The research was funded by the Beijing Natural Science Foundation(grant number 9232010)and Capital's Funds for Health Improvement and Research(grant number 2022-2-4079).
评论